Insights

Strategic Focus Emerging biotech with a novel light-based healing platform targeting respiratory diseases and at-home COVID-19 treatment, suggesting a potential need for remote patient monitoring, telehealth integrations, and at-home care partnerships.

Early Stage Opportunity Small team size (2-10 employees) and early-stage development indicate high receptivity to strategic collaborations, contract research, and problem-solving partnerships with larger biopharma or CROs to scale research and clinical activities.

Public Relations Growth Recent addition of a Head of Global Public Relations signals a focus on visibility, messaging, and communications, which can be paired with PR-led marketing bundles, corporate storytelling, and investor relations outreach.

Funding & Revenue Signal Moderate funding and revenue levels imply a need for efficient go-to-market support, grant assistance, and strategic financing conversations, as well as potential licensing or co-development deals to accelerate product timelines.

Tech & Security Readiness Listed tech stack emphasizes cloud, web, and security considerations; opportunities exist to propose cloud-hosted trial data platforms, secure collaboration tools, and regulatory-compliant data management solutions for clinical studies.

Similar companies to EmitBio Inc.

EmitBio Inc. Tech Stack

EmitBio Inc. uses 8 technology products and services including Linkedin Insight Tag, Amazon Web Services, WordPress, and more. Explore EmitBio Inc.'s tech stack below.

EmitBio Inc.'s Email Address Formats

EmitBio Inc. uses at least 1 email format:
EmitBio Inc. Email FormatsExamplePercentage
FLast@emitbio.comJDoe@emitbio.com
100%

Frequently Asked Questions

What is EmitBio Inc.'s official website and social media links?

Minus sign iconPlus sign icon
EmitBio Inc.'s official website is emitbio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does EmitBio Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, EmitBio Inc.'s annual revenue is estimated to be $1M - $10M.

What is EmitBio Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
EmitBio Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does EmitBio Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, EmitBio Inc. has approximately 7 employees across 1 continents, including North America. Key team members include Head Of Clinical Operations: M. M. Explore EmitBio Inc.'s employee directory with LeadIQ.

What industry does EmitBio Inc. belong to?

Minus sign iconPlus sign icon
EmitBio Inc. operates in the Biotechnology Research industry.

What technology does EmitBio Inc. use?

Minus sign iconPlus sign icon
EmitBio Inc.'s tech stack includes Linkedin Insight Tag, Amazon Web Services, WordPress, Shopify, Kinsta, Tailwind CSS, Apache HTTP Server and Sitelinks Search Box.

What is EmitBio Inc.'s email format?

Minus sign iconPlus sign icon
EmitBio Inc.'s email format typically follows the pattern of FLast@emitbio.com. Find more EmitBio Inc. email formats with LeadIQ.

How much funding has EmitBio Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, EmitBio Inc. has raised $2M in funding. The last funding round occurred on Nov 08, 2022 for $2M.

When was EmitBio Inc. founded?

Minus sign iconPlus sign icon
EmitBio Inc. was founded in 2020.
EmitBio Inc. logo

EmitBio Inc.

Biotechnology ResearchNorth Carolina, United States2-10 Employees

EmitBio Inc. is a biotechnology company based in Durham, North Carolina, focused on developing products across discovery, pre-clinical, and clinical stages. Its core approach uses precisely directed light to stimulate physiological signals and support cellular healing, with initial aims including an at-home treatment for COVID-19 and plans to expand toward a broader family of respiratory disease therapies. The company targets customers seeking advanced therapies for respiratory conditions, aiming to redefine standard care by delivering non-traditional, light-based interventions at various development stages. EmitBio operates as part of KNOW Bio, LLC, and is positioned within the biotechnology research sector as a small-scale organization pursuing innovative light-driven healing modalities. A recent development noted is the appointment of a Head of Global Public Relations to lead communications for the company.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconFunding & Financials

  • $2M

    EmitBio Inc. has raised a total of $2M of funding over 1 rounds. Their latest funding round was raised on Nov 08, 2022 in the amount of $2M as a Grant.

  • $1M - $10M

    EmitBio Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.